ATE546147T1 - Zusammensetzungen und verfahren zur behandlung und vorbeugung von kardiomyopathie und herzerkrankung - Google Patents

Zusammensetzungen und verfahren zur behandlung und vorbeugung von kardiomyopathie und herzerkrankung

Info

Publication number
ATE546147T1
ATE546147T1 AT06736222T AT06736222T ATE546147T1 AT E546147 T1 ATE546147 T1 AT E546147T1 AT 06736222 T AT06736222 T AT 06736222T AT 06736222 T AT06736222 T AT 06736222T AT E546147 T1 ATE546147 T1 AT E546147T1
Authority
AT
Austria
Prior art keywords
treating
methods
heart disease
compositions
preventing cardiomyopathy
Prior art date
Application number
AT06736222T
Other languages
English (en)
Inventor
Joseph Metzger
Dewayne Townsend
Soichiro Yasuda
Dan Michele
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE546147T1 publication Critical patent/ATE546147T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06736222T 2005-02-25 2006-02-27 Zusammensetzungen und verfahren zur behandlung und vorbeugung von kardiomyopathie und herzerkrankung ATE546147T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65657005P 2005-02-25 2005-02-25
PCT/US2006/006862 WO2006091941A2 (en) 2005-02-25 2006-02-27 Compositions and methods for treating and preventing cardiomyopathy and heart disease

Publications (1)

Publication Number Publication Date
ATE546147T1 true ATE546147T1 (de) 2012-03-15

Family

ID=36928113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06736222T ATE546147T1 (de) 2005-02-25 2006-02-27 Zusammensetzungen und verfahren zur behandlung und vorbeugung von kardiomyopathie und herzerkrankung

Country Status (8)

Country Link
US (2) US7846426B2 (de)
EP (1) EP1853280B1 (de)
JP (1) JP5042041B2 (de)
AT (1) ATE546147T1 (de)
AU (2) AU2006216420B2 (de)
CA (1) CA2599219C (de)
ES (1) ES2380047T3 (de)
WO (1) WO2006091941A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5537152B2 (ja) * 2006-08-01 2014-07-02 フリクサス ファーマシューティカルズ， インコーポレイテッド 慢性進行性心不全のための処置
CA2682234A1 (en) * 2007-04-05 2008-10-16 Phrixus Pharmaceuticals, Inc. Compositions and methods for the treatment of heart failure
EP2219546B1 (de) * 2007-11-29 2017-02-01 Genzyme Corporation Endoskopische schleimhaut-resektionierung mit gereinigten inversen wärmeempfindlichen polymeren
EP2234625B8 (de) 2007-12-17 2013-10-30 The Regents of the University of Michigan Zusammensetzungen und verfahren zur behandlung und prävention von skelettmuskel-mängeln
US9867547B2 (en) 2012-11-29 2018-01-16 Siemens Healthcare Gmbh System and method to calculate cardiac characteristics
EP2986301A4 (de) * 2013-04-19 2016-09-14 Cedars Sinai Medical Center Phosphodiesterase-5a-inhibitoren zur behandlung von muskeldystrophie
KR20160073391A (ko) * 2013-10-16 2016-06-24 매스트 테라퓨틱스 인코포레이티드 이뇨제 유도된 혈장량의 변화
AU2015287993B2 (en) 2014-07-07 2020-10-29 Liferaft Biosciences, Inc. A poloxamer composition free of long circulating material and methods for production and uses thereof
US9757411B2 (en) 2014-07-07 2017-09-12 Aires Pharmaceuticals, Inc. Poloxamer therapy for heart failure
WO2016007542A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. Poloxamer therapy for heart failure
EP3965734A4 (de) * 2019-05-06 2022-12-14 Arshintseva, Elena Valentinovna Verfahren zur erhöhung des hämoglobinspiegels von patienten mit krebs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992016484A1 (en) * 1991-03-19 1992-10-01 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
WO1992022202A1 (en) 1991-06-03 1992-12-23 Alpha Therapeutics Corporation Thrombolytic and perfluorochemical treatment for myocardial infraction
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
US6761824B2 (en) * 2000-08-17 2004-07-13 Reeve Lorraine E Process for the fractionation of polymers
EP1335707A4 (de) 2000-10-24 2005-07-06 Smithkline Beecham Corp Neue carvedilol-formulierungen

Also Published As

Publication number Publication date
EP1853280A4 (de) 2008-10-29
EP1853280B1 (de) 2012-02-22
AU2010214636A1 (en) 2010-09-16
CA2599219C (en) 2011-09-20
EP1853280A2 (de) 2007-11-14
JP2008531598A (ja) 2008-08-14
JP5042041B2 (ja) 2012-10-03
AU2006216420A1 (en) 2006-08-31
WO2006091941A2 (en) 2006-08-31
CA2599219A1 (en) 2006-08-31
US20110044935A1 (en) 2011-02-24
WO2006091941A3 (en) 2007-01-04
US8580245B2 (en) 2013-11-12
ES2380047T3 (es) 2012-05-08
AU2006216420B2 (en) 2010-07-15
US20080260681A1 (en) 2008-10-23
US7846426B2 (en) 2010-12-07

Similar Documents

Publication Publication Date Title
ATE546147T1 (de) Zusammensetzungen und verfahren zur behandlung und vorbeugung von kardiomyopathie und herzerkrankung
EA200501592A1 (ru) Способы и композиции для введения агонистов trpv1
EA200700965A1 (ru) Трегалоза и/или изомальтулоза в качестве носителя для сухой ароматической композиции
EA200970446A1 (ru) Связывающиеся с альбумином молекулы и их применение
CR20120649A (es) Compuestos, composiciones de tioacetato y métodos de uso
EA201390339A1 (ru) Замещенные имидазопиридазины
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
BR112015006828A8 (pt) composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; uso do composto; e método para modular a atividade de uma proteína ire1
EA200800172A1 (ru) 2,4-диаминопиримидины как ингибиторы aurora
EA201300323A1 (ru) Материалы и способы улучшения функции желудочно-кишечного тракта
EA201500431A1 (ru) Соединения боронатного эфира и его фармацевтические составы
BR112012032193A2 (pt) composto, composiçoes e métodos de uso de feniltioacetato
ECSP10010310A (es) Nuevos compuestos y composiciones y métodos de uso
EA201390772A1 (ru) Новые соли и полиморфные формы афатиниба
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
CO6361922A2 (es) Inhibidores del virus de la hepatitis c
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
RU2016135039A (ru) Композиция для обработки поверхностных дефектов
EA200700976A1 (ru) Соединения в виде молекул-конъюгатов, обладающих повышенной активностью в отношении включения клеткой
EA201170571A1 (ru) Способы и композиции для улучшения когнитивной функции
CL2007002689A1 (es) Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
EA201000277A1 (ru) Соединения для лечения гепатита с
EA201200046A1 (ru) Новые соединения, фармацевтическая композиция и связанные с ними способы
EA201001569A1 (ru) Инкапсуляция биологически активных агентов
EA201190344A1 (ru) Составы для лечения боли в глубоких тканях